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SCFAThe aimof this studywas to evaluate the effects of four beverage formulations (prebiotic— fructooligosaccharide,
probiotic — Lactobacillus casei Lc-01, synbiotic — fructooligosaccharide and L. casei Lc-01 and placebo) based on
aqueous extracts of soy and quinoa, towards the human intestinal microbiota using the Simulator of the
Human Intestinal Microbial Ecosystem (SHIME®), a dynamic model of the human gut. To monitor the effects
onmicrobial community composition, plate counts on speciﬁc growthmedia and a PCR–DGGE analysiswere per-
formed on samples from all colon compartments— ascending, transverse and descending. To verify the effects on
microbial metabolism, we analyzed the ammonium and short chain fatty acids (SCFAs) concentrations. The
synbiotic beverage showed the best microbiological results in the ascending colon compartment, stimulating
the growth of Lactobacillus spp. and Biﬁdobacterium spp., and reducing Clostridium spp., Bacteroides spp.,
enterobacteria and Enterococcus spp. populations in this compartment. A larger reduction (p b 0.05) of ammonia
ions in the ascending colon was observed during the synbiotic beverage treatment. No statistical difference was
observed in SCFA production among the treatments and the basal period. Plate count and DGGE analysis showed
the survival of L. casei Lc-01 in the colon. DGGE analysis also showed higher richness and diversity of the
Lactobacillus spp. community during the treatment with synbiotic beverage, with higher accentuation in the
ascending colon.
© 2014 Elsevier Ltd. All rights reserved.1. Introduction
The intestinal microbiota is a complex community of microorgan-
isms that colonizes the gastrointestinal tract. About 1014 intestinal mi-
crobes belonging to N1000 different species-level phylogenetic types
are distributed along the human gastrointestinal tract, with the highest
densities reach in the colon (Frick & Autenrieth, 2013; Payne, Zihler,
Chassard, & Lacroix, 2012; Rajilic-Stojanovic, Smidt, & De vos, 2007).
Although the colonicmicrobiota is relatively stable throughout adult
life, age-related changes in the gastrointestinal (GI) tract, as well as
changes in diet and immune system reactivity, inevitably affect popula-
tion composition (Woodmansey, 2007). Many efforts have focused on
the modulation of the colonic microbiota and its metabolic activities in
search of the community balance. The inclusion of foods containing pre-
biotics andprobiotics in thedaily diet can help to improve the gut healthl Sciences (UNESP), 1 Km Jau-
Brazil. Tel.: +55 16 33016932,by increasing the number of beneﬁcial bacteria and reducing the harm-
ful ones, in addition to alleviate diarrhea symptoms (Possemiers,
Marzorati, Verstraete, & Van de Wiele, 2010).
However, 16S rRNA-based cataloguing of gut microbiota via high-
throughput sequencing platforms does not provide information on the
functionality of any species identiﬁed. Unraveling the complexity ofmi-
crobe–microbe interactions and identifying niches central to gut fer-
mentation depend on functional studies. In vitro gut fermentation
models represent an innovative technological platform consisting of
multiple model designs, which permit investigations on the existence
of gut microbial species (Payne et al., 2012).
The Simulator of the Human Intestinal Microbial Ecosystem
(SHIME®) is an in vitro system proven to be a very useful model for nu-
trition studies, in terms of analysis of the intestinal microbial communi-
ty composition (Kontula et al., 2002; Molly, Vandewoestyne, Desmet, &
Verstraete, 1994; Possemiers et al., 2010; Sivieri et al., 2013). It is a ﬁve-
stage sequential reactor system simulating the different parts of the gas-
trointestinal tract, based on themodel developed byMolly et al. (1994),
optimized by De Boever, Deplancke, and Verstraete (2000) and validat-
ed by Possemiers, Verthé, Uyttendaele, and Verstraete (2004). The
SHIME harbors a stable microbial community, representative of the
44 F. Bianchi et al. / Food Research International 64 (2014) 43–52human gutmicrobiota, both in fermentation activity and in composition
(Molly et al., 1994).
The beverages used in this study, prepared with aqueous extracts of
quinoa and soy,were acidiﬁed by probioticmicroorganisms and/orwith
added fructooligosaccharide (FOS). These beverages may contribute to
the intestinal microbiota health, inﬂuenced by the probiotic and prebi-
otic action and the bioactive constituents of soy and quinoa. Besides
having all the essential amino acids and fatty acids of high quality
(ω6, ω3 and ω9), quinoa is an excellent example of functional food
that aims at lowering the risk of various diseases (Ando et al., 2002;
Vega-Gálvez et al., 2010). In addition, it is free from cholesterol, lactose
and gluten, as the soybean. The synbiotic beverage, based on aqueous
extract of soy and quinoa, presents proper physicochemical composi-
tion, and good acceptability and provides high viability to the probiotic
microorganism during storage. However, its action in the human intes-
tinal microbiota has not been studied and proven yet (Bianchi et al., un-
published data). Therefore, the aim of this study was to investigate the
capacity of the synbiotic, prebiotic, probiotic and placebo beverages,
based on aqueous extract of soy and quinoa, to temporarily modulate
the intestinal microbiota after oral administration using the SHIME® re-
actor system. This paper also evaluates the viability of L. casei Lc-01 after
the passage through simulated stomach and duodenum conditions.2. Material and methods
2.1. Production of quinoa and soy extracts
Quinoa grains were washed and rubbed manually in water to re-
move the antinutritional components (saponins) and, consequently, re-
duce the bitter aftertaste. They were immersed in water (55 g/L) and
boiled for 10 min. Later, the grains and water were blended to a homo-
geneousmixture, whichwasﬁltered on a 250mu-mesh screen to obtain
the extract.
The aqueous extract of soybean was produced by the Soy Derivative
Development and Production Unit, UNIVERSOJA, at the Faculty of Phar-
maceutical Sciences of UNESP (Araraquara, Brazil), as described by
Rossi, Vendramine, Carlos, Pei, and Valdez (1999).Table 2
Values of volume, residence time and pH established in each of the reactors of the SHIME2.2. Production of synbiotic, prebiotic, placebo and probiotic beverages
The four beverageswere producedwith 30% aqueous extracts of qui-
noa and 70% soy extract (89.5% of the extracts mixture), 6% sucrose
(União, Brazil), 0.8% soybean oil (Liza, Brazil), 1% food grade lactose
(Purac, Brazil), 0.14% Recodan TM RS-B stabilizer (Danisco, Brazil) and
2.5% milk powder (Molico, Brazil). All beverages were elaborated ac-
cording to Rossi, Reddy, and Silva (1984), differing only in acidiﬁcation
form and FOS content (Table 1).
All beverages were pasteurized prior to microorganism inoculation
or acidiﬁcation. Lactic acid PA (85%) was used to acidify the placebo
and prebiotic beverage to pH 4.8. In formulations with added FOS, 3%
of fructooligosaccharides (FOS-SKL Pharma, Brazil) was used after the
pasteurization.
A commercial lyophilized culture of Lactobacillus casei (Lc-01)
was activated in a milk medium (10% milk, 1% glucose, 0.5% yeast ex-
tract) (2% v/v) and kept at 37 °C for 15 h (until the stationary phase)
under aerobic conditions. Subsequently, 2% (v/v) of activated cultureTable 1
Differences in the preparation of synbiotic, prebiotic, probiotic and placebo beverages.
Beverage FOS Acidiﬁcation
Synbiotic (TS) + FOS Acidiﬁed with L. casei Lc-01
Prebiotic (Tpe) + FOS Artiﬁcially acidiﬁed
Probiotic (Tpo) − FOS Acidiﬁed with L. casei Lc-01
Placebo (Tpa) − FOS Artiﬁcially acidiﬁed(108 UFC/mL) was added to the synbiotic and probiotic beverages and
incubated at 37 °C until reaching pH 4.8.
2.3. Long-term SHIME run
The SHIME (registered tradename from Ghent University and
ProDigest) is a simulator of the human intestinal microbial ecosystem
(Molly et al., 1994) in which environmental conditions (pH, residence
time and temperature) are controlled (Table 2). It consists of ﬁve
double-jacketed vessels simulating the stomach, the duodenum, and
the ascending (R3), transverse (R4) and descending colon (R5) (Fig. 1).
The ﬁve reactor vessels were continuously stirred by means of a
magnetic stirrer and the temperature was kept at 37 °C. The system
was maintained anaerobically through a daily N2 ﬂushing of 30 min.
The pH culture of vessels 3, 4 and 5 was automatically adjusted by the
addition of NaOH 1 M or HCl 0.1 M and HCl 1 M for the stomach region
(Molly et al., 1994; Possemiers et al., 2004). Peristaltic pumps a–d
(Fig. 1) worked semi-continuously, while the remainder (e–g) worked
continuously, simulating the gastrointestinal tract.
2.4. Intestinal microbiota stabilization and experimental protocol
The reactor setup and the composition of the liquid feed (Table 3),
which entered the system three times per day, were previously de-
scribed by Possemiers et al. (2004).
The three colon vessels of the SHIME system were inoculated with
bacteria from a fecal sample of a healthy 26-year-old adult female
with no history of antibiotic treatment sixmonths prior to the study. Al-
iquots (20 g) of fresh fecal sampleswere diluted and homogenizedwith
100mLof sterilized phosphate buffer (0.1M/L, pH 6.5), containing 1 g/L
sodium thioglycolate as the reducing agent. The microbial inoculum
was stabilized over two weeks (basal period) on a carbohydrate-based
medium (liquid feed) and allowed to adapt to the speciﬁc environmen-
tal conditions of the ascending, transverse and descending colon, in
terms of pH range, retention time and available carbon sources (Molly
et al., 1994). After twoweeks of stabilization, treatments with synbiotic,
prebiotic, placebo and probiotic beverages were performed. The bever-
ages were added alongwith the basal feed in a proportion equivalent to
108 CFU/mL in the ﬁnal mixture. The protocol beganwith two weeks of
basal period followed by four weeks of treatment with synbiotic bever-
age (TS), twoweeks of post treatment (PT) (when the passage of bever-
ages was ceased, with only the liquid feed running in the system), two
weeks of prebiotic beverage treatment (TPe), two weeks of treatment
with the placebo beverage (TPa), ending with two weeks of probiotic
beverage treatment (TPo). The complete protocol, based on Kontula
et al. (2002), is shown in Fig. 2.
2.5. Viability of the probiotics in the stomach and duodenum
The viability of L. casei in the stomach and duodenum passages was
assessed in a sequential batch experiment designed to simulate the con-
ditions and residence time in these organs. The beverages were added
along with the liquid feed, a liquid start matrix based on a complex
feed, which is normally dosed to the SHIME in a proportion equivalent
to 108 CFU/mL in the ﬁnal mixture (Possemiers et al., 2004).system.
Source: Possemiers et al. (2004).
Reactor Volume (mL) Residence time (h) pH
R1: stomach 200 2.5 2.2–2.4
R2: duodenum 200 4.0 –
R3: ascending colon 500 20.0 5.6–5.9
R4: transverse colon 800 32.0 6.1–6.9
R5: descending colon 600 24.0 6.6–6.9
Reactor 5Reactor 4Reactor 3Reactor 2Reactor 1
8
7
1 2 3 4 5 6
b
a
fedc g
Fig. 1.Photography of Simulator of theHuman IntestinalMicrobial Ecosystem(SHIME®). Reactor 1= stomach; reactor 2= duodenum; reactor 3= ascendingcolon; reactor 4= transverse
colon; reactor 5= descending colon; a= pump that takes the sample to the stomach; b=pump that takes the pancreatic juice to the duodenum; c= Transfer pump of the stomach to the
duodenum; d= Transfer pumpof theduodenum to ascending colon; e= Transfer pumpof the ascending colon to transverse colon; f= transfer pumpof the transverse colon to descending
colon; g= transfer pump of the descending colon to the ﬁnal discard; 1= control pump of reactor 3 pH (acid); 2= control pump of reactor 3 pH (base); 3= control pump of reactor 4 pH
(acid); 4= control pump of reactor 4 pH (base); 5= control pump of reactor 5 pH (acid); 6= control pump of reactor 5 pH (base); 7= control pump of stomach pH (base); 8= control
pump of stomach pH (acid).
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under microaerophilic conditions for 1.5 h at 37 °C. Pancreatic solution
(per liter: 12.5 g NaHCO3, 6 g Oxgall and 0.9 g pancreatin) was added
and incubated under anaerobic conditions for 2 h at 37 °C to simulate
the duodenum environment. Before the start of the experiment and
after half and complete incubation under respective stomach and duo-
denum conditions, a sample was taken for plate count analysis to
assay the strain viability. One mL of each sample was suspended in
9 mL of peptone water. Serial dilutions were prepared and cultured on
MRS Agar (Himedia, India) at 37 °C/48 h under anaerobic conditions.
The evaluation of L. casei Lc-01 survival was also carried out using
the culture-independent molecular method: polymerase chain reac-
tion–denaturing gradient gel electrophoresis (PCR–DGGE). The used
protocol is explained below.2.6. Microbiological analyses
2.6.1. Plate counts
At weekly intervals, throughout the entire experimental period
(basal, treatments and post-treatment), 5 mL samples were collected
from the reactors for plate counts. The analysis of the intestinalmicrobi-
ota composition was based on the enumeration of total aerobic and an-
aerobic bacteria, Enterococcus spp., Lactobacillus spp., Biﬁdobacterium
spp., enterobacteria, Bacteroides spp. and Clostridium spp. One mL of a
sample taken from each reactor was suspended in 9 mL of peptoneTable 3
Ingredients (g) employed for each liter of the liquid feed used in the SHIME reactor.
Source: Payne et al.(2003).
Ingredients Quantity (g/L)
Starch (Maizena, Brasil) 3.0
Pectin (Vetec, Brasil) 2.0
Mucin (Sigma, USA) 4.0
Xylan (Sigma, USA) 1.0
Peptone (Acumedia, USA) 1.0
Arabinogalactan (Sigma, USA) 1.0
Glucose (Synth, Brasil) 0.4
Yeast extract (Acumedia, USA) 3.0
L-cysteine (Sigma, USA) 0.5
Sterile distilled water Amount required to complete 1 Lwater. Serial dilutions were prepared and inoculated into selective cul-
ture media, as shown in Table 4.
2.6.2. Behavior and diversity of Lactobacillus spp. in the colon
Molecular methods (PCR–DGGE) were used to analyze the behavior
and diversity of the Lactobacillus spp. community through the entire ex-
perimental period.
The QIAamp DNA Stool Mini Kit (Qiagen, Germany) was employed
to extract DNA from each reactor vessel, at each period of study and
from the lyophilized culture of L casei Lc-01. “Isolation of DNA from
Stool for Human DNA” (QIAGEN, 2010) was the protocol used in this
study with modiﬁcations in the amount of the initial sample (220 mg
to 2 mL) and AE buffer (200 mu to 50 mu). DNA yield was quantiﬁed
using a NanoDrop ND-1000 spectrophotometer (NanoDrop Technolo-
gies, USA). The speciﬁc primers used as starting point for DNA replica-
tion were Lab159f (5′-GGAAACAGATGCTAATACCG-3′) and Lab677GCr
(5′GCCCGGGGCGCGCCCCGGGCGGG GCGGGGGCACGGGGGGGCACCG
CTACACATGGAG-3′) (Heilig et al., 2002). PCR was performed using
the Taq polymerase (Invitrogen, Brazil). Samples were ampliﬁed in a
Veriti® 96-well thermal cycler (Applied Biosystems, USA) by using the
following program: initial denaturation at 94 °C for 2 min, 35 cycles of
denaturation at 94 °C for 30 s, annealing of primer at 56 °C for 40 s,
elongation at 72 °C for 1 min and extension at 72 °C for 5 min, followed
by a ﬁnal cooling to 4 °C.
Electrophoresis was carried out as previously described (Heilig et al.,
2002) in an8%polyacrylamide gelwith a denaturant gradient of 30–50%
for 16 h at 85 V in a 0.5× TAE buffer at a constant temperature of 60 °C.
Gels were stainedwith ethidiumbromide according to Sanguinetti, Dias
Neto, and Simpson (1994), scanned at 400 d.p.i., and further analyzed
by the BioNumerics 6.0 software (Applied Maths, Kortrijk, Belgium).
The distance matrices of each DGGE based on the Jaccard similarity
coefﬁcient to cluster the samples, were analyzed using the BioNumerics
6.0 software (Applied Maths, Kortrijk, Belgium).
2.6.3. Ecological interpretation of ﬁngerprint of Lactobacillus spp.
population
Ecological interpretation of ﬁngerprint (range-weighted rich-
ness and functional organization) was conducted as suggested by
Marzorati, Wittebolle, Boon, Daffonchio, and Verstraete (2008).
The range-weighted richness (Rr) is correlated with the distribution
of the bands in the DGGE pattern and the percentage denaturant
2 Weeks
Treatment 
with prebioc
beverage
Treatment 
with placebo
beverage
Treatment 
with probioc
beverage
Post-
Treatment
Treatment with
synbioc beverage
Basal Period
2 Weeks 2 Weeks 2 Weeks 2 Weeks4 Weeks
Fig. 2. Experimental SHIME® protocol.
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(within the limits of the technique). This concept can bemathematically
expressed by deﬁning an Rr index = (N2 × Dg), where N represents
the total number of bands in the pattern, and Dg the denaturing gradi-
ent comprised between the ﬁrst and the last band of the pattern
(Marzorati et al., 2008).
The functional organization (Fo) is the result of the action of themi-
croorganisms that are most ﬁtting to the ongoing environmental–
microbiological interactions (Marzorati et al., 2008). Pareto–Lorenz dis-
tribution curves were created to graphically represent the uniformity of
Lactobacillus spp. communities, based onDGGE proﬁle and evaluated on
the 20% level of the x axis, as previously described (Lorenz, 1905;
Mertens, Boon, & Verstraete, 2005; Wittebolle, Vervaeren, Verstraete,
& Boon, 2008).2.7. Ammonium analysis
Sampleswere collected once aweek from the vessels for ammonium
analysis, throughout the entire experimental period (basal, treatments
and post-treatment). The ammonia content was determined using a se-
lective ion meter (710A model, Orion) coupled to an ammonia
selective-ion electrode (Orion 95–12). The apparatus was calibrated
using 0.1 M standard ammonium chloride solutions, at 10, 100, and
1000 mg/L of ammonia. A total of 0.5 mL ISA solution (Ionic Strength
Adjuster, Orion), a pH-adjusting and ionic force solution, was added to
every 25 mL of sample. All measurements were carried out at 25 °C
(Bedani, 2008). The analyses were performed in triplicate.2.8. Analysis of short-chain fatty acids (SCFAs)
Samples were collected weekly from the reactors for SCFA analysis
throughout the entire experimental period (basal, treatments
and post-treatment). The analyses were carried out in triplicate
and the samples were frozen at−20 °C. The SCFAs were determined
using a gas chromatograph equipped with a ﬂame-ionization gas
detector, a capillary split/splitless injector and a HP-INNOWAX
column with a 30 m × 0.25 mm × 0.25 μm inlet (Shimadzu GC2010).
Hydrogenwas the carrier gas at aﬂow rate of 1.56 mL/min. The temper-
atures of the column, injector and detector were 170, 250 and 280 °C,
respectively (Van de Wiele, Boon, Possemiers, Jacobs, & Verstraete,
2007).Table 4
Culture medium and culture conditions used in plate count analysis.
Genus Culture medium Brand Time/temperatu
Lactobacillus MRS agar Himedia (India) 37 °C/48 h
Biﬁdobacterium Biﬁdo Medium BIM-25 Difco (France) 37 °C/72 h
Clostridium RCA agar Difco (France) 37 °C/48 h
Enterobacteia MacConkey agar Acumedia (USA) 37 °C/48 h
Enterococcus KF Streptococcus agar Acumedia (USA) 37 °C/48 h
Bacteroides BE agar Acumedia, (USA) 37 °C/120 h
Total anaerobes Standard methods agar Acumedia (USA) 37 °C/48 h
Facultative aerobes Standard methods agar Acumedia (USA) 37 °C/48 h2.9. Statistical analysis
The signiﬁcance of all results was investigated with one-way
ANOVA, and individual means were compared using the Tukey's test
(p b 0.05), using the Sigma Stat 5.0 software (Systat Software Inc., San
Jose, California).
3. Results and discussion
3.1. Viability of the probiotic in the stomach and duodenum
Plate counts showed an enhanced protection of L. casei Lc-01 with
the synbiotic beverage. There was no decrease in L. casei Lc-01 viability
under stomach conditions during the treatment with the synbiotic
beverage, although a reduction of 1 log CFU/mLwasobservedunder du-
odenum conditions (Fig. 3). In the treatment with the probiotic bever-
age, a signiﬁcant reduction in the viability of L. casei was observed
under stomach and duodenum conditions, indicating that the associa-
tion between the probiotic microorganism and prebiotic FOS provides
a positive effect on L. casei Lc-01 survival under acid conditions (Fig. 3).
Malolactic fermentation and histidine accumulation were revealed
as important features of acid adaptation in L. casei. Malolactic enzyme
was upregulated 16-fold and 7-fold following 5 and 20 min of acid ex-
posure, respectively. This enzyme functions to decarboxylate L-malate
to L-lactate and CO2, thus contributing to cytoplasm alkalization (Mills,
Stanton, Fitzgerald, & Ross, 2011).
Guergoletto, Magnani, Martin, Andrade, and Garcia (2010) afﬁrm
that L. casei Lc-01 has good resistance to the gastric and enteric juices.
According to Mishra and Prasad (2005), the ability to tolerate acid
and pancreatic juice can vary from one strain to another. Pozza,
Miglioranza, Garcia, Garcia, and Pozza (2011) studied different
Lactobacillus strains isolated from feces of children and conﬁrmed
eight strains resistant to acidic conditions and bile salts.
Xanthopoulos, Litopoulou-Tanetaki, and Tzanetakis (2000) afﬁrm
that bile salt resistance tends to vary between the lactic acid bacteria
and among strains of same species. According to Gilliland (1987) and
Saarela, Mogensen, Fondén, Matto, and Mattila-Sandholm (2000), bile
salts are toxic to cells because they disrupt the cellularmembrane struc-
ture and, therefore, bile salt tolerance is considered one of the required
characteristics for the survival of lactic acid bacteria in the duodenum.
Despite the reduction of L. casei Lc-01 population (1 log CFU/mL)
after the passage of the microorganism through the duodenum, in
both synbiotic and probiotic beverages, L. casei preserved the viabilityre Oxygen condition Reference
Anaerobiosis Yoshioka, Iseki, and Fujita (1983)
Anaerobiosis Munoa and Pares (1988)
Anaerobiosis Marzotto et al. (2006)
Anaerobiosis Brigidi, Vitali, Swennen, Bazzocchi, and Matteuzzi (2001)
Aerobiose Edlund et al. (2000)
Anaerobiosis Livingston, Kominos, and Yee (1978)
Anaerobiosis Yoshioka et al. (1983)
Aerobiose Yoshioka et al. (1983)
6.7
7.2
7.7
8.2
8.7
Beverage + liquid food Stomach Duodenum
Lo
g1
0 
 C
FU
/m
L
Treatment with synbioc beverage
Treatment with probioc beverageaB
aA
aA bA
bA
cA
Fig. 3. L. casei population (log CFU/mL) in synbiotic and probiotic beverages with added
liquid feed and under stomach and duodenum conditions. Different lowercase letters rep-
resent a signiﬁcant difference (p ≤ 0.05) in L. casei population to the same treatment be-
tween the two compartments and the liquid feed added to beverage, whereas different
uppercase letters represent a signiﬁcant difference (p ≤ 0.05) in L. casei population be-
tween the treatments.
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7.45 ± 0.14 log CFU/mL.
DGGE ﬁngerprints for lactobacilli (Fig. 4) indicated that L. casei Lc-01
survived the stomach and duodenum conditions and, subsequently,
reached the colon during the experiment period. In the last two weeks
of the treatment with synbiotic beverages (TS3 and TS4), there was an
intensiﬁcation of the bands that ran in the same position of the pure
L. casei Lc-01 culture (Fig. 4a). The inverse occurred in the post-
treatment (PT1 and PT2), when the passage of synbiotic beverage was
ceased. Fig. 4b shows that the appearance of equivalent bands to(a)
R3 (Ascending colon) R4 (Transve
B1 B2 TS1 TS2 TS3 TS4 PT1 PT2 L.c. B1 B2 TS1 TS2 TS
(b)
R3 (Ascending colon) R4 (Transvers
PT1 PT2 TPe1 TPe2 TPa1 TPa2 TPo1 TPo2 L.c.  PT1 PT2 TPe1 TPe2 TPa1
Fig. 4. L. casei survival in the three simulating colon regions by denaturing gradient gel electrop
beverages (b). B1: basal period (week 1); B2: basal period (week 2); TS1: synbiotic treatmen
synbiotic treatment (week 4); PT1: post-treatment (week 1); PT2: post-treatment (week 2); L
ment (week 2); TPa1: placebo treatment (week 1); TPa2: placebo treatment (week 2); TPo1:L. casei Lc-01 (control) is observed only when the treatment was per-
formed with the probiotic beverages (TPo). When the prebiotic (Tpe)
and placebo (TPa) beverages were analyzed, it is clear that few or no
band is visualized running in the same position of pure L. casei Lc-01 cul-
ture. According to Capela, Hay, and Shah (2006), the prebiotics provide
extra solids, which tend to protect cells from injury. Oligosaccharides
used in this study are hydrocolloids, which play a protective role to-
wards probiotic microorganisms (Desai, Powell, & Shah, 2004). This
way, the microorganism can provide its probiotic beneﬁcial effects
more effectively.3.2. L. casei Lc-01 capacity to temporarily colonize the colon in the SHIME
experiment
As reﬂected in the plate count data (Table 5), the administration
of the synbiotic beverage to the system induced a signiﬁcant increase
(p b 0.05) in lactobacilli counts, with a concentration increase of at least
1 log CFU/mL in the ascending colon compartment. Therewas an increase
of Biﬁdobacterium spp. and a decrease of Clostridium spp., Bacteroides spp.,
enterobacteria and Enterococcus spp. populations. Regarding the
other beverages, a decrease in Enterococcus spp., Clostridium spp. and
enterobacteria was observed. However, the results weremore signiﬁcant
(p b 0.05) in the treatment with synbiotic beverage, both in relation to
the increase of beneﬁcial bacteria and the reduction of pathogenic ones.
DGGE analysis was used to monitor qualitative changes in the com-
position and structure of the microbial communities in the three com-
partments simulating colon conditions. The dendrograms from the
ascending (R3), transverse (R4) and descending colon (R5) showedrse colon) R5 (Descending colon)
3 TS4 PT1 PT2 L.c. B1 B2 TS1 TS2 TS3 TS4 PT1 PT2 L.c.
e colon) R5 (Descending colon)
TPa2 TPo1 TPo2 L.c. PT1 PT2 TPe1 TPe2 TPa1 TPa2 TPo1 TPo2 L.c.
horesis (DGGE) during the treatments with synbiotic (a), prebiotic, placebo and probiotic
t (week 1); TS2: synbiotic treatment (week 2); TS3: synbiotic treatment (week 3); TS4:
.c. pure culture of L. casei Lc-01; TPe1: prebiotic treatment (week 1); TPe2: prebiotic treat-
probiotic treatment (week 1); TPo2: probiotic treatment (week 2).
Table 5
Average plate count measurements (±SEM), expressed in log CFU/mL, for the different microbial groups, SHIME® compartments and periods.
B TS PT Tpe TPa TPo
R3 (Ascending colon)
Lactobacillus spp. 7.88 ± 0.06C 8.39 ± 0.02A 8.40 ± 0.03A 7.29 ± 0.08D 8.04 ± 0.02B 8.11 ± 0.07B
Biﬁdobacterium spp. 7.75 ± 0.00C 8.21 ± 0.01B 8.44 ± 0.02A 7.48 ± 0.01D 7.31 ± 0.10E 7.82 ± 0.06C
Clostridium spp. 8.44 ± 0.04A 8.02 ± 0.00BC 8.35 ± 0.01AB 7.01 ± 0.01D 8.66 ± 0.01A 7.97 ± 0.01C
Enterococcus spp. 7.45 ± 0.21B 4.73 ± 0.07D 8.77 ± 0.01A 6.66 ± 0.08C 7.86 ± 0.09B 6.53 ± 0.28C
Enterobacteria 9.23 ± 0.07A 7.45 ± 0.03C 7.61 ± 0.06B 7.09 ± 0.00D 7.19 ± 0.07D 5.79 ± 0.04E
Total aerobes 8.20 ± 0.07A 7.74 ± 0.03B 8.39 ± 0.03A 7.68 ± 0.05B 7.27 ± 0. 02C 7.80 ± 0.02B
Facultative anaerobes 8.13 ± 0.05C 7.68 ± 0.05D 8.89 ± 0.03A 7.23 ± 0.11E 8.59 ± 0.05B 8.06 ± 0.02C
Bacteroides 4.94 ± 0.05B 2.58 ± 0.11D 4.43 ± 0.02B 5.46 ± 0.05A 5.47 ± 0.12A 4.04 ± 0.16C
R4 (Transverse colon)
Lactobacillus spp. 7.82 ± 0.02A 7.04 ± 0.03BC 6.91 ± 0.02C 7.40 ± 0.33B 6.36 ± 0.10D 7.01 ± 0.01C
Biﬁdobacterium spp. 7.56 ± 0.00A 7.02 ± 0.02B 7.10 ± 0.03B 6.82 ± 0.09C 5.06 ± 0.11E 6.30 ± 0.02D
Clostridium spp. 8.24 ± 0.04A 7.26 ± 0.13CD 7.40 ± 0.06C 7.11 ± 0.05D 7.93 ± 0.04B 6.85 ± 0.04E
Enterococcus spp. 7.09 ± 0.08B 4.61 ± 0.04E 7.98 ± 0.07A 6.90 ± 0.22B 6.16 ± 0.15C 5.42 ± 0.12D
Enterobacteria 7.69 ± 0.13A 6.19 ± 0.03D 7.09 ± 0.04B 7.46 ± 0.10A 6.40 ± 0.08D 6.62 ± 0.05C
Total aerobes 7.76 ± 0.09A 7.77 ± 0.08A 7.52 ± 0.00A 7.15 ± 0.14B 7.44 ± 0.24AB 6.68 ± 0.01C
Facultative anaerobes 7.82 ± 0.02A 6.87 ± 0.01BC 7.90 ± 0.09A 6.87 ± 0.22BC 5.75 ± 0.02D 6.66 ± 0.05C
Bacteroides 7.39 ± 0.01B 7.65 ± 0.07B 7.30 ± 0.09B 8.68 ± 0.26A 8.63 ± 0.27A 7.73 ± 0.27B
R5 (Descending colon)
Lactobacillus spp. 7.90 ± 0.06A 6.50 ± 0.03B 6.40 ± 0.09B 6.23 ± 0.15B 5.62 ± 0.29C 6.29 ± 0.08B
Biﬁdobacterium spp. 7.44 ± 0.07A 7.00 ± 0.01B 6.63 ± 0.00c 6.10 ± 0.13D 5.22 ± 0.16F 5.54 ± 0.27E
Clostridium spp. 8.24 ± 0.04A 7.26 ± 0.13C 7.69 ± 0.01B 6.73 ± 0.13D 8.14 ± 0.24A 6.47 ± 0.08D
Enterococcus spp. 7.21 ± 0.28A 4.94 ± 0.16EC 6.50 ± 0.01B 5.59 ± 0.38CD 5.48 ± 0.20DC 5.02 ± 0.21DE
Enterobacteria 7.73 ± 0.11A 6.77 ± 0.06B 6.50 ± 0.22BD 5.40 ± 0.41C 6.14 ± 0.09D 6.49 ± 0.09BD
Total aerobes 7.65 ± 0.13A 7.27 ± 0.64B 7.47 ± 1.03A 6.97 ± 0.29C 6.23 ± 0.97E 6.60 ± 0.11D
Facultative anaerobes 6.79 ± 0.08A 6.79 ± 0.05A 6.88 ± 0.00A 6.97 ± 0.10A 6.85 ± 0.02B 6.99 ± 0.07A
Bacteroides 7.78 ± 0.05BC 8.00 ± 0.11B 7.35 ± 0.02C 8.14 ± 0.06B 8.45 ± 0.28A 8.14 ± 0.34B
Different uppercase letters in the same line represent statistical difference (p b 0.05) between the treatments for the same reactor. B: basal period. TS: treatmentwith synbiotic beverage,
PT: Post-treatment, Tpe: treatment with prebiotic beverage, Tpo: treatment with probiotic beverage and TPa: treatment with placebo beverage.
48 F. Bianchi et al. / Food Research International 64 (2014) 43–52the formation of two major groups: from the synbiotic treatment (ST)
and other from the prebiotic, probiotic and placebo treatments, which
formed group I (Fig. 5). This division into two major groups with low
similarity (~20%) shows different Lactobacillus species in the SHIME re-
actor (Marzorati et al., 2010) during the different treatments and, there-
fore, changes in the Lactobacillus spp. community, particularly in the
synbiotic beverage treatment. The synbiotic beverage stimulated the
growth of several species of Lactobacillus in all reactors, which did not
occur with the other treatments. Fig. 4a shows an increase in the num-
ber of bands in the three reactors along the treatment with synbiotic
beverage. In contrast, there was a decrease in the number of bands dur-
ing the post-treatment and treatment with other beverages (Fig. 4b).
Similar results were found by Sivieri, Bianchi, and Rossi (2011) andR3                                              R4
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(week 2).Van de Wiele, Boon, Possemiers, Jacobs and Verstraete (2004), who re-
ported beneﬁcial effects of probiotics and prebiotics, respectively, in the
three colon regions, limited to the treatment period, thus requiring
continuous consumption of the studied component to obtain the
beneﬁcial effects. In addition, effect of probiotics on the growth
of colon lactobacilli was elucidated by a study of Chaikham and
Apichartsrangkoon (2014), who showed that the oral administration
of the encapsulated Lactobacillus acidophilus LA5 alongwith pasteurized
longan juice stimulated a signiﬁcant increase of lactobacilli (≥2 log
cycle) in all colon compartments in SHIME reactor. Molly, De Smet,
Nollet, DeWoestyne, and Verstraete (1996) showed that the quantities
of colon lactobacilli signiﬁcantly increased by 108 CFU/day after feeding
probiotics to the SHIME reactor.R5
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structure
There was a greater enrichment of lactobacilli population when the
treatment was carried out with the synbiotic beverage, both in the as-
cending and transverse colons. There is no difference in the descending
colon when compared to the basal period (Fig. 6). According to
Marzorati et al. (2008), Rr values below 10 indicate a low-richness0.0
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medium and high-richness populations, respectively, in terms of entire
community. The latter is characterized as a typical population of very
healthy environments, with a high microbial diversity (Marzorati
et al., 2008). This way, it is possible to say that R3 provided a healthier
environmentwhen treatedwith synbiotic beverage than other reactors,
resulting in a high-richness of lactobacilli and changing the diversity of
this population in a positive way. R4 also resulted in a richness increase0.6 0.8 1.0
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(R4)
(descending colon) from the SHIME® system, during the different treatments. Basal 1:
ynbiotic treatment (week 2); TS3: synbiotic treatment (week 3); TS4: synbiotic treatment
asei Lc-01; TPe1: prebiotic treatment (week 1); TPe2: prebiotic treatment (week 2); TPa1:
eek 1); TPo2: probiotic treatment (week 2).
Table 6
Average ammonium ion production (ppm) in SHIME® run during the different treatments.
Ascending colon Transverse colon Descending colon
Basal period 580.91 ± 109.71A 614.91 ± 60.22A 680.58 ± 49.38A
Synbiotic treatment 65.30 ± 14.05C 311.13 ± 25.15B 434.41 ± 44.43B
Post-treatment week 1 95.20 ± 7.46C 252.00 ± 6.24B 360.66 ± 8.32B
Post- treatment week 2 508.66 ± 20.30A 593.00 ± 17.57A 663.3 ± 15.27A
Prebiotic treatment 255.83 ± 140.24B 565.50 ± 101.12A 639.17 ± 28.05A
Placebo treatment 277.66 ± 12.66B 664.00 ± 17.34A 732.33 ± 24.17A
Probiotic treatment 332.66 ± 0.70B 588.33 ± 16.50A 693.50 ± 46.90A
Different uppercase letters in the same column represent statistical difference (p b 0.05)
between the different treatments.
50 F. Bianchi et al. / Food Research International 64 (2014) 43–52of lactobacilli species, but this contribution was lower than that provid-
ed by R3. No changes were observed in R5 richness during the treat-
ment with synbiotic beverage.
These results were expected because the pH in the colon (between
5.6 and 5.9) favors the growth of Lactobacillus spp., which explains the
higher richness of Lactobacillus spp. in the R3 reactor (Sivieri et al.,
2011).
In addition to the analysis on Lactobacillus spp. community richness,
a Pareto–Lorenz (PL) curve was also built, seeking a better understand-
ing of lactobacilli population behavior and its functionality in the differ-
ent treatments.
Except for the treatment with the prebiotic beverage at week 2
(TPe2) in R3, which showed a distance point from the other treatments,
there was an average of functionality coefﬁcient value of 43% between
the reactors. There were no great changes in the functionality of a reac-
tor to another and from one treatment to another (Fig. 7).0
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Fig. 8.Metabolic activity SCFA: acetic acid, propionic acid and butyric acid in reactor three, fou
among the samples were investigatedwith one-way ANOVA. Samples with the same letter on t
beverage, PT: post-treatment, Tpe: treatment with prebiotic beverage, Tpo: treatment with proAccording to Marzorati et al. (2008) and Carballa, Smits,
Etchebehere, Boon, and Verstraete (2011), in terms of entire communi-
ty, low (20–25%) and high (N80%) PL curves indicate a highly uniform
and specialized community, respectively. Consequently, a long lag
phase could be needed to counteract a sudden stress. A PL curve be-
tween 45 and 60% represents balanced communities, which can poten-
tially deal with changing environmental conditions while preserving
their functionality.
In view of this, it is possible to classify the lactobacilli population in
the three colon regions during different treatments, as a balanced com-
munity, capable of surviving at different environmental conditions
while maintaining its functionality. It indicates that even with the in-
crease or decrease of Lactobacillus species (proven by dependent and in-
dependent methods of cultivation) and other bacterial genera, in
accordance with the used treatment, there were no major changes in
the Lactobacillus spp. functional organization. Therefore, this population
remained stable and balanced throughout the study.
3.4. Ammonium ions
A signiﬁcant reduction in ammonia ions production in all reactors
during the treatment with synbiotic beverage, with greater intensity
in ascending colon, was observed. These values remained low until
the ﬁrst week after this treatment, with a large increase only in the sec-
ondweek of post-treatment, but nohigher than the control period value
(Table 6). This result is considered beneﬁcial because ammonia can alter
the morphology and the intermediary metabolism of intestinal cells
by increasing DNA synthesis and promoting colon carcinogenesis
(Ichikawa & Sakata, 1998).0
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51F. Bianchi et al. / Food Research International 64 (2014) 43–52Regarding the other beverages, there was a signiﬁcant reduction in
ammonia ions only in R3; however, this reduction was signiﬁcantly
lower when compared to the synbiotic beverage. There was no statisti-
cal difference among the prebiotic, probiotic and placebo beverages in
any of the three compartments, but they were all statistically different
from the synbiotic beverage. Kontula et al. (2002) found similar results
when evaluating the effect of lactulose on Lactobacillus rhamnosus sur-
vival using the SHIME system, suggesting changes in the metabolic
activity of the SHIME microbiota. In addition, similar effects with
L. acidophilus LA5 in pressurized longan juice induced lower ammonia
by 52.7, 59.5 and 50.4% in ascending, transverse, and descending
colons, respectively, in comparison with the controls (Chaikham &
Apichartsrangkoon, 2014).
In this study, R3 and R5 showed the lowest and highest amounts of
ammonia ions, respectively, independently of experimental period, cor-
roborating Kontula et al. (2002), Possemiers et al. (2004) and Sivieri
et al. (2011). According to Macfarlane, Gibson, and Cummings (1992),
the concentration of ammonia in the intestinal lumen increases pro-
gressively from the ascending to the descending colon, which is related
to a higher rate of protein fermentation in the descending colon
compared to the ascending colon (Davila et al., 2013). Smith and
Macfarlane (1998) attributed the lower production of ammonia from
the ascending colon to low pH and high carbohydrate availability in
this compartment.
3.5. Analysis of short-chain fatty acids (SCFAs)
No signiﬁcant increase in the SCFA production in the colon compart-
ments was observed during treatments compared to the basal period
(Fig. 8). Although the FOS and probiotic L. casei Lc-01 stimulated
(in combination or not) the growth of other Lactobacillus species, this
stimulation was not sufﬁcient to increase the production of SCFA, be-
cause the reactors had a limited amount of nutrients. Lactobacillus are
saccharolytic microorganisms and produce lactate, ethanol and succi-
nate as fermentation products, which are intermediates in the global
fermentation process in the microbiota, being metabolized to SCFA by
cross-feeding species in the ecosystem. Generally, these SCFAs do not
accumulate in the intestine due to low or insufﬁcient production
(Macfarlane &Macfarlane, 2003). Thesemicroorganisms cannot contin-
ue their normal cycle in the lack of nutrients, thereby reducing SCFA
accumulation.
SCFA concentrations are a temporary state, because the majority of
SCFA formed during the fermentation will be immediately used by
colonocytes or other intestinal bacteria (Topping & Clifton, 2001). Ac-
cording to Macfarlane and Gibson (1994), the formation of SCFA in the
gut depends on various factors. From a microbiological viewpoint, the
chemical composition, physical form and amount of substrate available
affect bacterial fermentation reactions, which are also dependent on the
types and numbers of different bacterial populations found in the gut,
catabolite regulatory mechanisms, the availability of inorganic electron
donors, as well as competitive and cooperative interactions between
different species in the microbiota (Allison & Macfarlane, 1988;
Macfarlane & Gibson, 1994).
4. Conclusions
The new beverage, based on aqueous extracts of quinoa and soy and
fortiﬁed by L. casei Lc-01 and the prebiotic FOS, had the greatest beneﬁ-
cial action on the intestinal microbiota. The synbiotic beverage showed
more signiﬁcant effects in the ascending colon, increasing Lactobacillus
spp. and Biﬁdobacterium spp. populations and reducing detrimental
genera to the host, such as Bacteroides and Clostridium spp. It also signif-
icantly reduced production of ammonia ions in this compartment, and
improved the diversity and richness of the Lactobacillus spp. community
without affecting its functionality. Although the prebiotic and probiotic
beverages had good results regarding the increase of commensalbacteria, the reduction of ammonia ions and pathogenic bacteria,
these results were not as satisfactory as those provided by the synbiotic
beverage. Therefore, the synbiotic beverage is a good matrix candidate
for the intestinal delivery of probiotics, which helps the indigenous mi-
crobiota to improve human health.
Acknowledgments
The authors would like to acknowledge the Fundação de Amparo à
Pesquisa do Estado de São Paulo (FAPESP) for the ﬁnancial support
given to this project no. 2011/08110-4.
References
Allison, C., & Macfarlane, G. T. (1988). Effect of nitrate on methane production and fer-
mentation in slurries of human faecal bacteria. Journal of General Microbiology, 134,
1397–1405.
Ando, H., Chen, Yi-chun, Tang, H., Shimizu, M., Watanabe, K., & Mitsunaga, T. (2002). Food
components in fractions of quinoa seed. Food Science and Technology Research, 8,
80–84.
Bedani, R. (2008). Inﬂuência do consumo de “iogurte” de soja fermentado com Enterococcus
faecium CRL 183 na microbiota intestinal de animais e humanos. (M.Sc. Dissertation).
Araraquara, São Paulo, Brasil: Faculdade de Ciências Farmacêuticas, UNESP, 140.
Brigidi, P., Vitali, B., Swennen, E., Bazzocchi, G., & Matteuzzi, D. (2001). Effects of probiotic
administration upon the composition and enzymatic activity of human fecal microbi-
ota in patients with irritable bowel syndrome or functional diarrhea. Research in
Microbiology, 152, 735–774.
Capela, P., Hay, T. K. C., & Shah, N. P. (2006). Effect of cryoprotectants, prebiotics and
microencapsulation on survival of probiotic organisms in yoghurt and freeze-dried
yoghurt. Food Research International, 39, 203–211.
Carballa, M., Smits, M., Etchebehere, C., Boon, N., & Verstraete, W. (2011). Correlations be-
tween molecular and operational parameters in continuous lab-scale anaerobic reac-
tors. Applied Microbiology and Biotechnology, 89, 303–314.
Chaikham, P., & Apichartsrangkoon, A. (2014). Effects of encapsulated Lactobacillus
acidophilus along with pasteurized longan juice on the colon microbiota residing in
a dynamic simulator of the human intestinal microbial ecosystem. Applied
Microbiology and Biotechnology, 8, 485–495.
Davila, A. -M., Blachiera, F., Gotteland, M., Mireille Andriamihaja, M., Benettia, P. -H.,
Sanzc, Y., et al. (2013). Intestinal luminal nitrogen metabolism: Role of the gut micro-
biota and consequences for the host. Pharmacological Research, 68, 95–107.
De Boever, P., Deplancke, B., & Verstraete, W. (2000). Fermentation by gut microbiota cul-
tured in a Simulator of the human intestinal microbial ecosystem is improved by
supplementing a soygerm powder. Journal of Nutrition, 130, 2599–2606.
Desai, A. R., Powell, I. B., & Shah, N. P. (2004). Survival and activity of probiotic lactobacilli
in skim milk containing prebiotics. Journal of Food Science, 69, 57–60.
Edlund, C., Beyer, G., Hiemer-Bau, M., Ziege, S., Lode, H., & Nord, C. E. (2000). Comparative
effects of mixiﬂoxacin and clarithromycin on normal intestinal microﬂora.
Scandinavian Journal of Infectious Diseases, 32, 81–85.
Frick, J. S., & Autenrieth, I. B. (2013). The gut microﬂora and its variety of roles in health
and disease. Current Topics in Microbiology and Immunology, 358, 273–289.
Gilliland, S. E. (1987). Importance of bile tolerance in lactobacilli used as dietary adjunct.
In T. P. Lyons (Ed.), Biotechnology in the feed industry (pp. 149–155). Lexingto: Alltech
Feed Co.
Guergoletto, K. B., Magnani, M., Martin, J. S., Andrade, C. G. T. J., & Garcia, S. (2010). Sur-
vival of Lactobacillus casei (LC-1) adhered to prebiotic vegetal ﬁbers. Innovative Food
Science and Emerging Technologies, 11, 415–421.
Heilig, H. G., Zoetendal, E. G., Vaughan, E. E., Marteau, P., Akkermans, A. D., & De vos, W. M.
(2002). Molecular diversity of Lactobacillus spp. and other lactic acid bacteria in the
human intestine as determined by speciﬁc ampliﬁcation of 16S ribosomal DNA.
Applied and Environmental Microbiology, 68, 114–123.
Ichikawa, H., & Sakata, T. (1998). Stimulation of epithelial cell proliferation of isolated dis-
tal colon of rats by continuous colonic infusion of ammonia or short-chain fatty acids
is nonadditive. Journal of Nutrition, 128, 843–847.
Kontula, P., Nollet, L., Saarela, M., Vilpponen-Salmela, T., Verstraete, W., Mattila-
Sandholm, T., et al. (2002). The effect of lactulose on the survival of Lactobacillus
rhamnosus in the simulator of the human intestinal microbial ecosystem (SHIME®)
and in vivo. Microbial Ecology in Health and Disease, 14, 90–96.
Livingston, S. J., Kominos, S. D., & Yee, R. B. (1978). New medium for selection and pre-
sumptive identiﬁcation of Bacteroides fragilis group. Journal of Clinical Microbiology,
7, 448–453.
Lorenz, M. O. (1905). Methods of measuring concentration of wealth. Journal of the
American Statistical Association, 9, 209–219.
Macfarlane, G. T., & Gibson, G. R. (1994). Metabolic activities of the normal colonic ﬂora. In
S. Gibson (Ed.), Human health: The contribution of microorganisms (pp. 17–52).
London: Springer.
Macfarlane, G. T., Gibson, G. R., & Cummings, J. H. (1992). Comparison of fermentation re-
actions in different regions of the human colon. Journal of Applied Bacteriology, 72,
57–64.
Macfarlane, S., & Macfarlane, G. T. (2003). Regulation of short-chain fatty acid production.
Proceedings of the Nutrition Society, 62, 67–72.
Marzorati, M., Verhelst, A., Luta, G., Sinnott, R., Verstraete, W., Van de Wiele, T., et al.
(2010). In vitro modulation of the human gastrointestinal microbial community by
52 F. Bianchi et al. / Food Research International 64 (2014) 43–52plant-derived polysaccharide-rich dietary supplements. International Journal of Food
Microbiology, 139, 168–176.
Marzorati, M., Wittebolle, L., Boon, N., Daffonchio, D., & Verstraete, W. (2008). How to get
more out of molecular ﬁngerprints: Practical tools for environmental microbiology.
Environmental Microbiology, 10, 1571–1581.
Marzotto, M., Maffeis, C., Paternoster, T., Ferrrario, R., Rizzotti, L., Pellegrino, M., et al.
(2006). Lactobacillus paracasei A survives gastrointestinal passage and affects the
fecal microbiota of healthy infants. Research in Microbiology, 157, 857–866.
Mertens, B., Boon, N., & Verstraete,W. (2005). Stereospeciﬁc effect of hexachlorocyclohex-
ane on activity and structure of soil methanotrophic communities. Environmental
Microbiology, 7, 660–669.
Mills, S., Stanton, C., Fitzgerald, G. F., & Ross, R. P. (2011). Enhancing the stress responses
of probiotics for a lifestyle from gut to product and back again.Microbial Cell Factories,
10, 1–19.
Mishra, V., & Prasad, D. N. (2005). Application of in vitro methods for selection of
Lactobacillus casei strains as potential probiotics. International Journal of Food
Microbiology, 103, 109–115.
Molly, K., De Smet, I., Nollet, L., De Woestyne, V., & Verstraete, W. (1996). Effect of
lactobacilli on the ecology of the gastro-intestinal microbiota cultured in the SHIME
reactor. Microbiol Ecology in Health and Disease, 9, 79–89.
Molly, K., Vandewoestyne, M., Desmet, I., & Verstraete, W. (1994). Validation of the sim-
ulator of the human intestinal microbial ecosystem (SHIME) reactor using microor-
ganism associated activities. Microbial Ecology in Health and Disease, 7, 191–200.
Munoa, F. J., & Pares, R. (1988). Selective medium for isolation and enumeration of
Biﬁdobacterium spp. Applied and Environmental Microbiology, 54, 1715–1718.
Payne, S., Gibson, G., Wynne, A., Hudspith, B., Brostoff, J., & Tuohy, K. (2003). In vitro
studies on colonization resistance of the human gut microbiota to Candida albicans
and the effects of tetracycline and Lactobacillus plantarum LPK. Current Issues in
Intestinal Microbiology, 4, 1–8.
Payne, A. N., Zihler, A., Chassard, C., & Lacroix, C. (2012). Advances and perspectives in
in vitro human gut fermentation modeling. Trends in Biotechnology, 30, 17–25.
Possemiers, S., Marzorati, M., Verstraete, W., & Van de Wiele, T. (2010). Bacteria and
chocolate: A successful combination for probiotic delivery. International Journal of
Food Microbiology, 141, 97–103.
Possemiers, S., Verthé, K., Uyttendaele, S., & Verstraete, W. (2004). PCR–DGGE-based
quantiﬁcation of stability of the microbial community in a simulator of the human in-
testinal microbial ecosystem. FEMS Microbiology Ecology, 49, 495–507.
Pozza, M. S. S., Miglioranza, L. H. S., Garcia, J. E., Garcia, S., & Pozza, P. C. (2011). Human
gastrointestinal tract resistance of Lactobacillus strains isolated from infant faeces.
Semina: Ciências Agrárias, 32, 1021–1032.
QIAGEN (2010). QIAamp® DNA Stool Handbook (2th ed.) (http://www.qiagen.com).
Rajilic-Stojanovic, M., Smidt, H., & De vos, W. M. (2007). Diversity of the human gastroin-
testinal tract microbiota revisited. Environmental Microbiology, 9, 2125–2136.Rossi, E. A., Reddy, K. V., & Silva, R. S. S. F. (1984). Formulation of soy-whey yogurt, using
response surface methodology. Brazilian Archives of Biology and Technology, 27,
387–390.
Rossi, E. A., Vendramine, R. C., Carlos, I. Z., Pei, Y. C., & Valdez, G. F. (1999). Development of
a novel fermented soymilk product with potential probiotic properties. European
Food Research and Technology, 209, 305–307.
Saarela, M., Mogensen, G., Fondén, R., Matto, J., & Mattila-Sandholm, T. (2000). Probiotic
bacteria: Safety, functional and technological properties. Journal of Biotechnology,
84, 197–215.
Sanguinetti, C. J., Dias Neto, E., & Simpson, A. J. G. (1994). Rapid silver staining and recov-
ery of PCR products separated on polyacrylamide gels. Biotechniques, 17, 915–919.
Sivieri, K., Bianchi, F., & Rossi, E. A. (2011). Fermentation by gut microbiota cultured in a
simulator of the human intestinal microbial ecosystem is improved probiotic
Enterococcus faecium CRL 183. Functional Foods in Health and Disease, 10, 389–402.
Sivieri, K., Morales, M. L. V., Adorno, M. A. T., Sakamoto, I. K., Saad, S. M. I., & Rossi, E. A.
(2013). Lactobacillus acidophilus CRL 1014 improved “gut health” in the SHIME® re-
actor. Gastroenterology, 13, 100–109.
Smith, E. A., & Macfarlane, G. T. (1998). Enumeration of amino acid fermenting bacteria in
the human large intestine: effects of pH and starch on peptide metabolism and dis-
similation of amino acids. FEMS Microbiology Ecology, 25, 355–368.
Topping, D. L., & Clifton, P. M. (2001). Short-chain fatty acids and human colonic function:
Roles of resistant starch and nonstarch polysaccharides. Physiological Reviews, 81,
1031–1064.
Van deWiele, T., Boon, N., Possemiers, S., Jacobs, H., & Verstraete, W. (2004). Prebiotic ef-
fect of chicory inulin in the simulator of the human intestinal microbial ecosystem.
FEMS Microbiology Ecology, 51, 143–153.
Van de Wiele, T., Boon, N., Possemiers, S., Jacobs, H., & Verstraete, W. (2007). Inulin-type
fructans of longer degree of polymerization exert more pronounced in vitro prebiotic
effects. Journal of Applied Microbiology, 102, 452–460.
Vega-Gálvez, A., Miranda, M., Vergara, J., Uribe, E., Puente, I., & Martínez, E. A. (2010).
Nutrition facts and functional potential of quinoa (Chenopodium quinoa willd.), an
ancient Andean grain: A review. Journal of the Science of Food and Agriculture, 90,
2541–2547.
Wittebolle, L., Vervaeren, H., Verstraete, W., & Boon, N. (2008). Quantifying community
dynamics of nitriﬁers in functionally stable reactors. Applied and Environmental
Microbiology, 74, 286–293.
Woodmansey, E. J. (2007). Intestinal bacteria and ageing. Journal of Applied Microbiology,
102, 1178–1186.
Xanthopoulos, V., Litopoulou-Tanetaki, E., & Tzanetakis, N. (2000). Characterization of
Lactobacillus isolates from infant faeces as dietary adjuncts. Food Microbiology, 17,
205–215.
Yoshioka, H., Iseki, K., & Fujita, K. (1983). Development and difference of intestinal ﬂora in
the neonatal period in breast-fed and bottle-fed infants. Pediatrics, 72, 317–321.
